CPIX - CIK 0001087294
The table below shows CUMBERLAND PHARMACEUTICALS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2025 | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.01M | $15.20M | $16.09M | $17.46M | $17.34M | $18.55M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $14.26M | $10.43M | $10.32M | $11.31M | $11.62M | $10.65M |
| Inventory | $5.45M | $2.93M | $3.22M | $4.51M | $4.30M | $4.33M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $32.79M |
| $29.94M |
| $31.21M |
| $35.24M |
| $35.58M |
| $36.21M |
| Property, plant & equipment | $237.38K | $293.38K | $297.79K | $312.03K | $337.09K | $369.50K |
| Goodwill | $914.00K | $914.00K | $914.00K | $914.00K | $914.00K | $914.00K |
| Total assets | $71.00M | $65.90M | $67.91M | $76.75M | $78.52M | $81.51M |
| Accounts payable | $16.54M | $13.83M | $13.45M | $12.06M | $12.51M | $13.08M |
| Total current liabilities | $34.49M | $24.31M | $23.97M | $31.09M | $24.76M | $26.43M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $49.69M | $40.10M | $40.23M | $52.28M | $52.49M | $54.32M |
| Retained earnings | -$30.09M | -$25.39M | -$23.45M | -$22.06M | -$20.52M | -$19.43M |
| Total equity | $21.64M | $26.12M | $27.99M | $24.78M | $26.35M | $27.49M |